This Edition
ARTICLE | Clinical News
SPN810: Phase IIa started
WIR Staff
February 9, 2009 8:00 AM UTC
Supernus began an open-label, U.S. Phase IIa trial to evaluate oral SPN810 in up to 72 patients. ...